Renal Cancer - Results from #120

Oncologic surveillance after surgical treatment for clinically localized kidney cancer: UroCCR study n. 129. September 27, 2024

Clinical application of radiomics for the prediction of treatment outcome and survival in patients with renal cell carcinoma: a systematic review. September 27, 2024

Renal Cell Carcinoma with a Catastrophic Thrombus: A Case Report. September 27, 2024

Evaluating the Impact of a Shared Decision-making Intervention for Patients with Renal Cell Carcinoma: The SDM-RCC Study Protocol. September 26, 2024

Prognostic models for predicting oncological outcomes after surgical resection of a nonmetastatic renal cancer: A critical review of current literature. September 26, 2024

Clinical Impact of the CARMENA Trial on Cytoreductive Nephrectomy Practices in the USA: A Difference-in-differences Analysis. September 25, 2024

CT-Guided Online Adaptive Radiotherapy Delivered via Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR) for a Bulky Thoracic and Abdominal Mass in Oligometastatic Renal Cell Carcinoma. September 25, 2024

Development and validation of a CT based radiomics nomogram for preoperative prediction of ISUP/WHO grading in renal clear cell carcinoma. September 24, 2024

Belzutifan Efficacy and Tolerability in Patients with Sporadic Metastatic Clear Cell Renal Cell Carcinoma. September 24, 2024

Renal Mass Biopsy is Associated With Fewer Radical Nephrectomies for Benign or Indolent Disease, Particularly for T1b Renal Masses. September 23, 2024

Adjuvant Nivolumab for Localized Renal Cell Carcinoma at High Risk of Recurrence After Nephrectomy: Part B of the Randomized, Placebo-Controlled, Phase III CheckMate 914 Trial. September 23, 2024

Belzutifan for patients with von Hippel-Lindau disease-associated CNS haemangioblastomas (LITESPARK-004): a multicentre, single-arm, phase 2 study. September 20, 2024

Acceptance of emerging renal oncocytic neoplasms: a survey of urologic pathologists. September 20, 2024

Chinese expert consensus on the systemic treatment of advanced clear cell renal cell carcinoma (2024 edition). September 20, 2024

Microwave vs radiofrequency ablation for small renal masses: perioperative and oncological outcomes. September 19, 2024

Real-World Primary Resistance to First-Line Immune-Based Combinations in Patients with Advanced Renal Cell Carcinoma (ARON-1). September 19, 2024

Upfront Versus Deferred Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: A Systematic Review and Individual Patient Data Meta-analysis. September 19, 2024

Long-read RNA sequencing of archival tissues reveals novel genes and transcripts associated with clear cell renal cell carcinoma recurrence and immune evasion. September 18, 2024

Tivozanib plus nivolumab versus tivozanib monotherapy in patients with renal cell carcinoma following an immune checkpoint inhibitor: results of the phase 3 TiNivo-2 Study. September 18, 2024

Role of Cytoreductive Nephrectomy in Metastatic Clear Cell Renal cell Carcinoma in the Era of immunotherapy: An Analysis of the National Cancer Database. September 17, 2024

Page 7 of 456